All treatments
Treatment
Pozelimab, Cemdisiran clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic confirmatory (Phase III)
A Single Arm Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria with Inadequate Control of Intravascular Hemolysis on Currently Available C5 Inhibitor Therapy
This study looks at a new drug combination, Pozelimab and Cemdisiran, for adults with a rare blood condition called PNH. It aims to see if these drugs can better control the condition for those whose current treatments aren't working well enough. The main goal is to reduce a marker of blood cell damage.
For: Paroxysmal nocturnal hemoglobinuria (PNH)Poland · Italy · Spain - Active not recruitingPHASE3
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
This study is testing new drug combinations, pozelimab and cemdisiran, for adults with a muscle-weakening condition called generalised myasthenia gravis (gMG). It looks at how safe these drugs are and how well they help improve muscle function.
For: Generalized Myasthenia GravisUnited States · Belgium · Brazil